FBT

First Trust NYSE Arca Biotechnology Index Fund

NYSEArcaUSDEQUITY DELAYED

270.95

▲ 2.82 (1.05%)

MARKET · —

Price

Open

268.13

Prev close

268.13

Day high

272.80

Day low

269.31

Volume

37.98K

Market cap

—

P/E (TTM)

—

52W range

171.00 – 272.80

Trailing performance

Price return · vs SPY

Returnvs SPY

+6.08% +7.4%

+8.89% +5.2%

+27.51% +24.4%

+29.95% +18.9%

YTD

+31.20% +18.9%

+56.30% +36.3%

+78.41% +4.2%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

261.89

+3.46% from price

SMA 20

255.55

+6.03% from price

SMA 50

248.13

+9.20% from price

SMA 100

229.16

+18.24% from price

SMA 200

218.03

+24.27% from price

EMA 12

261.39

+3.66% from price

EMA 26

255.43

+6.07% from price

EMA 50

247.36

+9.54% from price

RSI (14)

70.3

Overbought

MACD (12,26,9)

5.96

Hist 1.41

ATR (14)

4.21

1.55% of price

Realised vol 30D

22.0%

Annualised

Bollinger upper

271.32

20, 2σ

Bollinger lower

239.77

20, 2σ

50 / 200 cross

Golden

248.13 vs 218.03

Trend bias

Above 200

+24.27%

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.78

Less volatile than market

Correlation to SPY

0.46

Loosely linked

Realised vol 30D

22.0%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-14.3%

Peak to trough

Max drawdown 5Y

-29.9%

Peak to trough

ATR 14

4.21

1.55% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 270.95

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

FBT · links out to the publisher

The Zacks Analyst Blog Highlights Amgen, Crinetics, FBT, BBH and BBP Zacks · 2d ago Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth Zacks · 2d ago FBT and IBB Are Not the Same Biotech Bet, and 5 Years of Returns Prove It 24/7 Wall St. · 26d ago Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? Zacks · 43d ago Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? Zacks · 51d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.